Lessons learnt from pharmacovigilance audits and inspections
In drug development, maintaining high data quality is essential for regulatory success and patient safety. Discover key lessons and strategies helping sponsors and marketing authorization holders to navigate audits and inspections more confidently—from early development to post-approval activities.
Takeaways
- Gain insight into impacts of poor vs. high-quality pharmacovigilance data
- Understand the importance of readiness for audits and inspections
- Know how to avoid other common pitfalls related to pharmacovigilance data
Lunch is included, with limited spots available
